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Background:  Carcinoid tumors are rare, with an incidence of 1 in 100,000 of the general population. Carcinoid heart disease can be the 
initial presentation of carcinoid tumors in up to 20-50% of the cases. 
case:  A 25-year-old woman presenting to our outpatient cardiology clinic with a 4-year history of progressive shortness of breath. Physical 
examination was significant for an ejection systolic murmur, heard best at the left upper sternal border grade 3/6, radiating to the back, with 
a pan-systolic 3/6 murmur at left lower sternal border that increases with inspiration, and a faint rumbling diastolic murmur heard at the left 
lower sternal border, lung examination was significant for wheezes and abdominal examination revealed hepatomegaly. 
decision Making:  A trans-thoracic echocardiogram (ECHO) revealed mild right ventricular hypertrophy, with a normal function, a thickened 
tricuspid valve with restricted leaflet motion, severe tricuspid regurgitation and evidence of a thickened pulmonary valve (mean gradient 
35mmHg). A cardiac MRI confirmed these finding. A CT scan showed evidence of a larger liver with multiple hyper-vascular lesions, with 
similar lesions in the mesentery and small bowel, suggestive of a metastatic tumor. Twenty-four hour urine for 5-Hydroxyindoleacetic 
acid came back positive and liver biopsy revealed a neuro-endocrine tumor. At a multidisciplinary tumor board, the decision was to treat 
the patient medically with octreotide and chemotherapy (capecitabine and temozolanide) and to repeat the ECHO every 3-6 months for 
assessment of the valve disease progression. 
conclusion:  Carcinoid heart disease should be considered in the differential diagnosis of right-sided valve lesions. Dyspnea due to 
carcinoid syndrome is multifactorial and caused early by bronchospasm from the release of vaso-active amines.
